Show simple item record

dc.contributor.advisorGately, Kathy
dc.contributor.authorForde, Lydia
dc.date.accessioned2017-01-18T16:30:10Z
dc.date.available2017-01-18T16:30:10Z
dc.date.issued2012
dc.identifier.citationLydia Forde, 'The role of insulin-like growth factor 1 receptor (IGF-IR) in non-small cell lung cancer (NSCLC)', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Clinical Medicine, 2012, pp 266
dc.identifier.otherTHESIS 9586
dc.identifier.urihttp://hdl.handle.net/2262/78989
dc.description.abstractLung cancer is the most common cause of cancer related death in Ireland and worldwide. Despite modest advances in traditional cytotoxic chemotherapy, survival rates remain disappointing at approximately 15%. Targeted therapies such as EGFR tyrosine kinase inhibitors (TKIs) provide some improvement in clinical outcomes. However the development of resistance to these drugs remains a major problem in the treatment of cancer. The rationale for investigating new targeted agents and the use of combination therapies is clear.
dc.format1 volume
dc.language.isoen
dc.publisherTrinity College (Dublin, Ireland). School of Medicine. Discipline of Clinical Medicine
dc.relation.isversionofhttp://stella.catalogue.tcd.ie/iii/encore/record/C__Rb15120771
dc.subjectClinical Medicine, Ph.D.
dc.subjectPh.D. Trinity College Dublin
dc.titleThe role of insulin-like growth factor 1 receptor (IGF-IR) in non-small cell lung cancer (NSCLC)
dc.typethesis
dc.type.supercollectionthesis_dissertations
dc.type.supercollectionrefereed_publications
dc.type.qualificationlevelDoctoral
dc.type.qualificationnameDoctor of Philosophy (Ph.D.)
dc.rights.ecaccessrightsopenAccess
dc.format.extentpaginationpp 266
dc.description.noteTARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ie


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record